Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Cytomos

Cytomos
2012 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Early Stage VC LATEST DEAL TYPE
$2.13M LATEST DEAL AMOUNT
2 INVESTORS
Description

Developer of a medical diagnostics technology designed to assist in label-free cell analysis for biomedical research. The company's patented cell analysis technology ensures that every cell is analysed providing granular information on individual cells and the whole sample population, facilitates automated and quantitative sample assessment, phenotypic drug discovery and stem cell therapy, enabling medical researchers to find functional end points that conventional assays cannot reach and generate high-content fingerprints to select the right dose for the right patients, thereby making cell-based diagnostics quicker and simpler.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
  • 13 Melville Street
  • Edinburgh EH3 7PE
  • Scotland, United Kingdom
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Cytomos’s full profile, request a free trial.

Cytomos Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 23-Apr-2018 $2.13M 00.000 00.000 Completed Startup
2. Early Stage VC 16-Feb-2016 00000 00000 00.000 Completed Startup
1. Angel (individual) 15-Dec-2014 $157K $157K 00000 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Cytomos Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Ordinary 000,000 00.000000 000.00 000.00 00 000.00 00.000
Ordinary 000,000 00.000000 00.00 00.00 00 00.00 00.000
Ordinary 19,800 $0.000014 $7.14 $7.14 1x $7.14 4.78%
To view this company’s complete Cap Table, request access »

Cytomos Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Scottish Enterprise Venture Capital Minority 000 0000 000000 0
Archangel Investors Angel Group Minority 000 0000 000000 0

Cytomos Executive Team (1)

Name Title Board
Seat
Contact
Info
Keith Muir Ph.D Founder & Chief Executive Officer

Cytomos Board Members (3)

Name Representing Role Since Contact
Info
Alister Minty Self Chairman 000 0000
Gino Miele Ph.D Self Board Member 000 0000
Margaret Temple Self Board Member 000 0000